2,5,7,8-tetramethyl-(2R-(4R, 8R,12-trimethyltridecyl)-chroman-6-yloxy) propionic acid | 261929-53-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2,5,7,8-tetramethyl-(2R-(4R, 8R,12-trimethyltridecyl)-chroman-6-yloxy) propionic acid
• 英文别名: 3-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]propanoic acid
• CAS: 261929-53-7
• 化学式: C₃₂H₅₄O₄
• 分子量: 502.778
• InChiKey: OOAFDZRLYBYHIH-GOFIJKOKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  10.5
• 重原子数：
  36
• 可旋转键数：
  16
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
  申请人：Research Development Foundation

  公开号：US20040235938A1

  公开（公告）日：2004-11-25

  The present invention provides an antiproliferative compound having the structural formula 1 wherein X is oxygen, nitrogen or sulfur; Y is selected from the group consisting of oxygen, nitrogen and sulfur wherein when Y is oxygen or nitrogen, n is 1 and when Y is sulfur, n is 0. Also provided is a method for inducing apoptosis in a cell comprising administering a composition comprising a compound.

  本发明提供一种抗增殖化合物，其结构式为1，其中X为氧、氮或硫；Y选自氧、氮和硫的群体，其中当Y为氧或氮时，n为1，当Y为硫时，n为0。还提供了一种诱导细胞凋亡的方法，包括给予含有该化合物的组合物。
• TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF
  申请人：Sanders Bob G.

  公开号：US20080161349A1

  公开（公告）日：2008-07-03

  The present invention provides an antiproliferative compound having a structural formula where X and Y independently are oxygen, nitrogen or sulfur; R 1 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, carboxylic acid, carboxylate, carboxamide, ester, thioamide, thiolacid, thiolester, saccharide, alkoxy-linked saccharide, amine, sulfonate, sulfate, phosphate, alcohol, ethers or nitriles; R 2 and R 3 are hydrogen or R 4 ; R 4 is methyl, benzyl carboxylic acid, benzyl carboxylate, benzyl carboxamide, benzylester, saccharide or amine; and R 1 is alkenyl; where when Y is nitrogen, said nitrogen is substituted with R 6 , wherein R 6 is hydrogen or methyl. Also provided are methods for treating a cell proliferative disease and for inducing apoptosis in a cell comprising administering this compound is also provided.

  本发明提供了一种抗增殖化合物，其具有以下结构式： 其中，X和Y独立地为氧、氮或硫；R1为烷基、烯基、炔基、芳基、杂环芳基、羧酸、羧酸盐、羧酰胺、酯、硫代酰胺、巯基酸、巯基酯、糖、烷氧基连接的糖、胺、磺酸盐、硫酸盐、磷酸盐、醇、醚或腈；R2和R3为氢或R4；R4为甲基、苄基羧酸、苄基羧酸盐、苄基羧酰胺、苄基酯、糖或胺；R1为烯基；当Y为氮时，所述氮被R6取代，其中R6为氢或甲基。本发明还提供了治疗细胞增殖性疾病和诱导细胞凋亡的方法，包括给予该化合物。
• Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
  申请人：Sanders Bob G.

  公开号：US20120251616A1

  公开（公告）日：2012-10-04

  The present invention provides an antiproliferative compound having a structural formula where X and Y independently are oxygen, nitrogen or sulfur; R 1 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, carboxylic acid, carboxylate, carboxamide, ester, thioamide, thiolacid, thiolester, saccharide, alkoxy-linked saccharide, amine, sulfonate, sulfate, phosphate, alcohol, ethers or nitriles; R 2 and R 3 are hydrogen or R 4 ; R 4 is methyl, benzyl carboxylic acid, benzyl carboxylate, benzyl carboxamide, benzylester, saccharide or amine; and R 5 is alkenyl; where when Y is nitrogen, said nitrogen is substituted with R 6 , wherein R 6 is hydrogen or methyl. Also provided are methods for treating a cell proliferative disease and for inducing apoptosis in a cell comprising administering this compound is also provided.

  本发明提供了一种抗增殖化合物，其具有以下结构式： 其中X和Y分别是氧、氮或硫；R1是烷基、烯基、炔基、芳基、杂环芳基、羧酸、羧酸盐、羧酰胺、酯、硫代酰胺、硫酸酸、硫酸酯、糖、糖基醚、胺、磺酸盐、硫酸盐、磷酸盐、醇、醚或腈；R2和R3是氢或R4；R4是甲基、苯甲酸、苯甲酸盐、苯甲酰胺、苯酯、糖或胺；R5是烯基；当Y是氮时，所述氮被R6取代，其中R6是氢或甲基。本发明还提供了治疗细胞增殖性疾病和诱导细胞凋亡的方法，包括给予该化合物。
• TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF
  申请人：Santolecan Pharmaceuticals LLC

  公开号：US20210228530A1

  公开（公告）日：2021-07-29

  The present invention pertains to a group of taxane-lipid-polysaccharide dual conjugates of the Formula I, a process for the preparation thereof, uses thereof, and pharmaceutical compositions comprising the same. The invention also relates to a series of intermediates for the preparation of taxane-lipid-polysaccharide dual conjugates, a process for their preparation, and their use as drug delivery vehicles.
• US6645998B2
  申请人：——

  公开号：US6645998B2

  公开（公告）日：2003-11-11